Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, Shoenfeld Y
Center for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, Israel.
Clin Dev Immunol. 2005 Sep;12(3):197-202. doi: 10.1080/17402520500233510.
To compare the diagnostic utility of laboratory variables, including matrix metalloproteinase-3 (MMP-3), anticyclic citrullinated peptide (CCP) antibodies, rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) in patients with erosive and non-erosive rheumatoid arthritis (RA).
We assembled a training set, consisting of 60 patients with RA, all fulfilling the revised criteria of the American College of Rheumatology. A commercial enzyme linked immunosorbent assay (ELISA) was used both to test for anti-CCP antibodies (second generation ELISA kit) and MMP; RF were detected by latex-enhanced immunonephelometric assay. CRP was measured by latex turbidimetric immunoassay.
The levels of anti-CCP antibody titers and ESR were significantly higher in patients with erosive disease than those in non-erosive RA patients (p < 0.001 and 0.0341) respectively. Moreover, a higher frequency of elevated titers of anti-CCP antibodies was found in RA patients with erosions compared to patients with non-erosive RA (78.3% vs. 43.2% respectively). The ROC curves of anti-CCP passed closer to the upper left corner than those other markers and area under the curve (AUC) of anti-CCP was significantly larger than AUC of other markers (0.755 for anti-CCP, 0.660 for ESR, 0.611 for CRP, 0.577 for RF, and 0.484 for MMP-3 female). A positive predictive value was higher for anti-CCP antibodies in comparison to other markers. We did not find significant statistical correlation between anti-CCP antibody titers and inflammatory markers such as ESR or CRP. However, we confirmed the correlation of elevated titers of anti-CCP antibodies and RF in both groups of patients whereas the degree of correlation was more significant in non-erosive patients.
The results of our study suggest that the presence of elevated anti-CCP antibody titers have better diagnostic performance than MMP-3, RF, CRP and ESR in patients with erosive RA.
比较实验室指标,包括基质金属蛋白酶-3(MMP-3)、抗环瓜氨酸肽(CCP)抗体、类风湿因子(RF)、红细胞沉降率(ESR)和C反应蛋白(CRP)在侵蚀性和非侵蚀性类风湿关节炎(RA)患者中的诊断效用。
我们组建了一个训练集,由60例RA患者组成,所有患者均符合美国风湿病学会修订标准。采用商业酶联免疫吸附测定(ELISA)检测抗CCP抗体(第二代ELISA试剂盒)和MMP;采用乳胶增强免疫比浊法检测RF。采用乳胶比浊免疫测定法测量CRP。
侵蚀性疾病患者的抗CCP抗体滴度水平和ESR分别显著高于非侵蚀性RA患者(p < 0.001和0.0341)。此外,与非侵蚀性RA患者相比,侵蚀性RA患者中抗CCP抗体滴度升高的频率更高(分别为78.3%和43.2%)。抗CCP的ROC曲线比其他标志物的曲线更靠近左上角,抗CCP的曲线下面积(AUC)显著大于其他标志物的AUC(抗CCP为0.755,ESR为0.660,CRP为0.611,RF为0.577,女性MMP-3为0.484)。抗CCP抗体的阳性预测值高于其他标志物。我们未发现抗CCP抗体滴度与ESR或CRP等炎症标志物之间存在显著统计学相关性。然而,我们证实了两组患者中抗CCP抗体滴度升高与RF之间的相关性,而在非侵蚀性患者中相关性程度更显著。
我们的研究结果表明,在侵蚀性RA患者中,抗CCP抗体滴度升高的诊断性能优于MMP-3、RF、CRP和ESR。